Magle Chemoswed Holding AB (publ) (STO:MAGLE)

Sweden flag Sweden · Delayed Price · Currency is SEK
4.460
+0.620 (16.15%)
Apr 10, 2026, 5:07 PM CET
Market Cap92.10M -86.3%
Revenue (ttm)287.55M +19.5%
Net Income-159.89M
EPS-7.74
Shares Out20.65M
PE Ration/a
Forward PE3.19
Dividendn/a
Ex-Dividend Daten/a
Volume58,832
Average Volume13,830
Open3.840
Previous Close3.840
Day's Range3.840 - 4.500
52-Week Range3.680 - 30.000
Beta0.47
RSI29.52
Earnings DateMay 15, 2026

About STO:MAGLE

Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease. The company also offers EmboCept S, a microsphere-based medical dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1944
Employees 140
Stock Exchange Nasdaq Stockholm
Ticker Symbol MAGLE
Full Company Profile

Financial Performance

Financial Statements